U.S. FDA proposes modernizing non-prescription drug reviews

WASHINGTON, Feb 21 (Reuters) - The U.S. Food and Drug Administration is proposing sweeping changes to its 40-year-old system for approving over-the-counter drugs to make it quickly adaptable to scientific changes.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.